Skip to content

The impact of jumping exercise and collagen supplementation on bone turnover markers in healthy males

The impact of jumping exercise and collagen supplementation on bone turnover markers in healthy males - CollaJump

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON51015
Enrollment
30
Registered
2021-04-19
Start date
2021-04-20
Completion date
Unknown
Last updated
2024-04-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

botgezondheid Bone health osteoporosis

Interventions

Study 1a: for 3 days, volunteers will consume either a collagen protein supplement (20 g
1 or 2 x p/d) or an isocaloric placebo supplement (maltodextrin
1 x p/d), additional to their habitual diet, combined with a 5 minute jumping exercise session. Study 1b: for 2 days, volunteers will consume either a collagen protein supplement (20 g
2 x p/d), additional to their habitual diet, combined with a 5 minute jumping session or no intervention.

Sponsors

HAN University of Applied Sciences
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Male Age *18 and *35 years. BMI *18.5 and *27.5 kg/m2 Willing to give blood samples

Exclusion criteria

Exclusion criteria: * Blood donation during the study period * Currently smoking * Severe allergy to nuts or intolerance to gluten, as supplements are being produced in factory that may have used nuts or gluten previously * Consumption of >21 alcoholic beverages per week * Use of antibiotics in the past month * Medical condition that can interfere with the study outcome (i.e. cardiovascular disease, pulmonary disease, rheumatoid arthritis, orthopaedic disorders, renal disease, liver disease, diabetes mellitus, inflammatory disease, cognitive impairment, and thyroid or parathyroid disease)) * Use of medications known to interfere with selected outcome measures (i.e. corticosteroids, , statins, fenofibrate, beta-blocker) * (Chronic) injuries of the locomotor system that can interfere with the intervention. * Current participation in another biomedical research study.

Design outcomes

Primary

MeasureTime frame
Bone turnover markers: P1NP and B-CTX

Secondary

MeasureTime frame
Parathyroid hormone, testosterone, calcium

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)